{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:50:10Z","timestamp":1791910210429,"version":"4.3.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Persistent candidemia is associated with increased mortality, yet prognostic markers beyond initial blood culture time to positivity (TTP) remain poorly defined. While the TTP ratio between follow-up blood cultures (FUBCs) has shown prognostic utility in persistent Staphylococcus aureus bacteremia, its role in persistent candidemia has not been established. We aimed to evaluate the impact of changes in TTP across serial blood cultures in people with candidemia persisting for \u226548\u2005hours and to assess their association with clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-center retrospective study including adult patients with candidemia and persistently positive FUBC \u226548\u2005hours despite active antifungal therapy. Time to positivity and TTP ratio were analyzed according to clinical, microbiological, and outcome variables. The association with 30-day mortality was assessed using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 544 people with candidemia, 69 with persistent candidemia were included. The median TTP ratio was 1.4 (1.1\u20132.3). Patients with a shorter TTP ratio (&amp;lt;1.4) had numerically higher 30-day mortality, 7-day mortality, and in-hospital mortality, but in no cases was this statistically significant. The duration of antifungal exposure was not correlated with TTP prolongation. Thirty-day mortality was 36.2% and was associated in the multivariate model with septic shock, while catheter-related infection was protective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall mortality was numerically higher among those with shorter prolongation of FUBC TTP, although a statistical difference was not reached. No significant TTP prolongation was observed in sequential blood cultures despite active antifungal therapy. Further studies are needed to optimize therapeutic strategies against tolerant and persistent Candida strains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main points<\/jats:title>\n                    <jats:p>In people with persistent candidemia, a lower time-to-positivity (TTP) ratio (&amp;lt;1.4) had numerically higher mortality but was not statistically significant, likely due to the low number of events. Thirty-day mortality was associated in the multivariate model with septic shock, while catheter-related infection was protective. Duration of antifungal treatment was not associated with TTP prolongation. Further studies are needed to optimize management of persistent Candida strains.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag619","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:40:41Z","timestamp":1790682041000},"source":"Crossref","is-referenced-by-count":0,"title":["Sequential Time to Positivity as a Prognostic Indicator in Persistent Candidemia"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-670X","authenticated-orcid":false,"given":"Marta","family":"Albanell-Fern\u00e1ndez","sequence":"first","affiliation":[{"name":"Pharmacy Service, Division of Medicines, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Department of Physiological Science, School of Medicine, University of Barcelona , L'Hospitalet de Llobregat, Barcelona ,","place":["Spain"]},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vergara","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institute of Global Health (ISGlobal) , Barcelona ,","place":["Spain"]},{"name":"CIBERINFEC, CIBER in Infectious Diseases, ISCIII , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-8279","authenticated-orcid":false,"given":"Marta","family":"Bodro","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"CIBERINFEC, CIBER in Infectious Diseases, ISCIII , Madrid ,","place":["Spain"]},{"name":"Infectious Diseases Department, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4822-1024","authenticated-orcid":false,"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"Institute of Global Health (ISGlobal) , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8476-7629","authenticated-orcid":false,"given":"Paula","family":"Juan","sequence":"additional","affiliation":[{"name":"Microbiology Department, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6946-233X","authenticated-orcid":false,"given":"Josep","family":"Mensa","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Infectious Diseases Department, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Tuset","sequence":"additional","affiliation":[{"name":"Pharmacy Service, Division of Medicines, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Herrera","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"CIBERINFEC, CIBER in Infectious Diseases, ISCIII , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lex","family":"Soriano","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Faculty of Medicine, University of Barcelona , Barcelona ,","place":["Spain"]},{"name":"CIBERINFEC, CIBER in Infectious Diseases, ISCIII , Madrid ,","place":["Spain"]},{"name":"Infectious Diseases Department, Hospital Clinic of Barcelona, University of Barcelona , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"2026101312120838500_ofag619-B1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106586","article-title":"Persistent candidemia caused by different Candida species: data from a multicenter contemporary cohort","volume":"91","author":"Tiseo","year":"2025","journal-title":"J Infect"},{"key":"2026101312120838500_ofag619-B2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106629","article-title":"Risk factors for persistent candidemia and prognostic implications: results from the ECMM Candida III study","volume":"91","author":"Sedik","year":"2025","journal-title":"J Infect"},{"key":"2026101312120838500_ofag619-B3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12879-023-08241-9","article-title":"Epidemiology, antifungal susceptibility, risk factors, and mortality of persistent candidemia in adult patients in China: a 6-year multicenter retrospective study","volume":"23","author":"Li","year":"2023","journal-title":"BMC Infect Dis"},{"key":"2026101312120838500_ofag619-B4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/myc.13085","article-title":"Persistent vs non-persistent candidaemia in adult patients in 2007-2016: a retrospective cohort study","volume":"63","author":"Ala-Houhala","year":"2020","journal-title":"Mycoses"},{"key":"2026101312120838500_ofag619-B5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jinf.2018.05.011","article-title":"Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: a time-dependent analysis","volume":"77","author":"Lin","year":"2018","journal-title":"J Infect"},{"key":"2026101312120838500_ofag619-B6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10096-019-03477-3","article-title":"Persistent candidemia in adults: underlying causes and clinical significance in the antifungal stewardship era","volume":"38","author":"Agnelli","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026101312120838500_ofag619-B7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jinf.2017.05.019","article-title":"Clinical characteristics and risk factors for mortality in adult patients with persistent candidemia","volume":"75","author":"Kang","year":"2017","journal-title":"J Infect"},{"key":"2026101312120838500_ofag619-B8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2026.106798","article-title":"Defining the threshold duration of candidemia associated with poor outcomes: redefining persistent candidemia","volume":"93","author":"Albanell-Fern\u00e1ndez","year":"2026","journal-title":"J Infect"},{"key":"2026101312120838500_ofag619-B9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2026101312120838500_ofag619-B10","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026101312120838500_ofag619-B11","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1093\/jac\/dkt256","article-title":"Clinical impact of time to positivity for Candida species on mortality in patients with candidaemia","volume":"68","author":"Kim","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2026101312120838500_ofag619-B12","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad028","article-title":"Time-to-positivity in bloodstream infection for Candida species as a prognostic marker for mortality","volume":"61","author":"Keighley","year":"2023","journal-title":"Med Mycol"},{"key":"2026101312120838500_ofag619-B13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2026.108847","article-title":"Time to positivity as a diagnostic tool for catheter-related candidemia: a species-specific analysis","volume":"170","author":"Albanell-Fern\u00e1ndez","year":"2026","journal-title":"Int J Infect Dis"},{"key":"2026101312120838500_ofag619-B14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1099\/jmm.0.038166-0","article-title":"Time to positivity of blood cultures of different Candida species causing fungaemia","volume":"61","author":"Lai","year":"2012","journal-title":"J Med Microbiol"},{"key":"2026101312120838500_ofag619-B15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/mmy\/myy097","article-title":"Growth kinetics in Candida spp.: differences between species and potential impact on antifungal susceptibility testing as described by the EUCAST","volume":"57","author":"Bordallo-Cardona","year":"2019","journal-title":"Med Mycol"},{"key":"2026101312120838500_ofag619-B16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.diagmicrobio.2009.04.002","article-title":"Time to positive culture and identification for Candida bloodstream infections","volume":"64","author":"Fernandez","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026101312120838500_ofag619-B17","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cmi.2018.12.001","article-title":"Blood culture time-to-positivity: making use of the hidden information","volume":"25","author":"Lamy","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2026101312120838500_ofag619-B18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/1469-0691.12608","article-title":"Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia","volume":"20","author":"Hsu","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2026101312120838500_ofag619-B19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae173","article-title":"Sequential time to positivity as a prognostic indicator in Staphylococcus aureus bacteremia","volume":"11","author":"Comba","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026101312120838500_ofag619-B20","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"2026101312120838500_ofag619-B21","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s10096-012-1648-0","article-title":"Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia","volume":"31","author":"Choi","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026101312120838500_ofag619-B22","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1038\/s41467-023-41509-x","article-title":"Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures","volume":"14","author":"Badrane","year":"2023","journal-title":"Nat Commun"},{"key":"2026101312120838500_ofag619-B23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/infdis\/jiaf495","article-title":"Blood cultures contain populations of genetically diverse Candida albicans strains that may differ in echinocandin tolerance and fitness","volume":"233","author":"Fleres","year":"2026","journal-title":"J Infect Dis"},{"key":"2026101312120838500_ofag619-B24","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat Commun"},{"key":"2026101312120838500_ofag619-B25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2024.102439","article-title":"Beyond resistance: antifungal heteroresistance and antifungal tolerance in fungal pathogens","volume":"78","author":"Yang","year":"2024","journal-title":"Curr Opin Microbiol"},{"key":"2026101312120838500_ofag619-B26","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1093\/infdis\/jiae631","article-title":"Candida albicans recovered from persistent candidemia exhibits enhanced virulence traits","volume":"231","author":"Ribeiro","year":"2025","journal-title":"J Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag619\/71547779\/ofag619.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/10\/ofag619\/71547779\/ofag619.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/10\/ofag619\/71547779\/ofag619.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:12:15Z","timestamp":1791907935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag619\/8857685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,29]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag619","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,29]]},"article-number":"ofag619"}}